Protocol Design Featured Articles
-
Insights From A Digital Health Intervention Trial For Heart Failure
3/18/2025
University of Twente’s Mark Schuuring, MD, Ph.D. explores how digital health tools can successfully support heart failure interventions, despite hesitancy from providers and skepticism about the interest and abilities of a more senior patient population.
-
Invest In This One Thing To Help Strengthen Your ClinOps Team
3/13/2025
As clinical research faces unprecedented transformation in trial conduct, sponsor companies that will survive — and thrive — are the ones investing in their people.
-
Takeda's Diversity Strategy Pays Off For Phase 3 Trial
3/12/2025
LaShell Robinson, head of global feasibility and trial equity at Takeda explains how the company’s Phase 3 trial for a psoriasis drug ended enrollment well before it’s goal and achieved some impressive diversity metrics.
-
Social Media And A Site-Less Model Led This Trial To Pandemic-Era Success
3/10/2025
Genescopy's Chief Science and Medical Officer Erica Barnell, MD, Ph.D. explains how social media recruiting and a site-less trial design helped the company's CRC-PREVENT Phase 3 trial succeed.
-
Bridging Clinical Research And Care With TransCelerate's Rob DiCicco
3/7/2025
TransCelerate's Rob DiCicco offers insights into why bridging clinical care and research matters and the challenges that must be overcome to realize the vision.
-
Lessons Learned From Vivani Medical's Study Of GLP-1 Implant
3/5/2025
Vivani Medical Cofounder and CEO Adam Mendelsohn, Ph.D. discusses the company’s first application of the NanoPortal, including its upsides for patient adherence, its optimized trial design, and its reception among sites and patients.
-
4 Crucial Differences Between Early-Phase And Late-Phase Trial Site Selection
2/28/2025
Learn the differences between early-phase and late-phase trial site selection, including what makes an ideal site for early-phase trials, where speed, precision, and adaptability are non-negotiable.
-
Understanding Lupus Trial Participation And The Importance Of Patient Support
2/27/2025
Lupus Therapeutics Director of Patient Engagement Caroline Donovan explores the challenges of patient enrollment and heralds the role of patient support in running successful trials for lupus patients.
-
Day One Bio's Talks With FDA Help Secure Glioma Drug Approval
2/14/2025
Day One CMO Elly Barry, MD recounts the company's experience working with the FDA and turning a passed-over drug into its first-ever approved treatment for pediatric glioma patients.
-
Harness MDIC's Collaborative Resources to Strengthen Clinical Trials and Patient Outcomes
2/13/2025
Discover how resources from the Medical Device Innovation Consortium (MDIC) can help advance clinical trials for better patient outcomes.